The Innovative Medicines Initiative −10 Years of Public-Private Collaboration

The Innovative Medicines Initiative −10 Years of Public-Private Collaboration

The Innovative Medicines Initiative (IMI) is a public-private partnership between the European Union and the European pharmaceutical industry. Born of the necessity to foster collaboration between different stakeholders in order to address growing challenges in bringing new medicines to market and t...

Full description

Bibliographic Details
Main Authors: Hugh Laverty, Pierre Meulien
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-12-01
Series:Frontiers in Medicine
Subjects:
public-private partnership
healthcare
medicines
innovation
multi-stakeholder
society
Online Access:https://www.frontiersin.org/article/10.3389/fmed.2019.00275/full

Internet

https://www.frontiersin.org/article/10.3389/fmed.2019.00275/full

Similar Items